The estimated Net Worth of Howard Benjamin is at least $10.1 millió dollars as of 14 December 2017. Howard Benjamin owns over 12,729 units of Repligen stock worth over $6,687,746 and over the last 16 years Howard sold RGEN stock worth over $3,447,885.
Howard has made over 12 trades of the Repligen stock since 2013, according to the Form 4 filled with the SEC. Most recently Howard exercised 12,729 units of RGEN stock worth $305,623 on 14 December 2017.
The largest trade Howard's ever made was exercising 102,036 units of Repligen stock on 5 June 2014 worth over $448,958. On average, Howard trades about 16,466 units every 94 days since 2009. As of 14 December 2017 Howard still owns at least 46,637 units of Repligen stock.
You can see the complete history of Howard Benjamin stock trades at the bottom of the page.
Howard's mailing address filed with the SEC is C/O REPLIGEN CORPORATION, 41 SEYON STREET, WALTHAM, MA, 02453.
Over the last 22 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir és Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: